Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets. Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based diagnostic tests for brain health and other conditions.
Sector: Measuring & Controlling Devices, NEC
Industry: Biotechnology
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 2.94M shares outstanding
USNiki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences.
The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets.
Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based diagnostic tests for brain health and other conditions.
Chung Yuen Huen
Founder, CEO & Executive Director
Kwok Kuen Wong
Head of Finance
Employees
1
Country
US
Sector
Healthcare
Website
aptorumgroup.com
Loading congressional disclosures…
based on 2.94M shares outstanding
US30d Avg
35.26K
60d Avg
142.11K
90d Avg
173.63K
